| Literature DB >> 19762290 |
Pranavan Thillaivinayagalingam1, Julien Gommeaux, Michael McLoughlin, David Collins, Anthony R Newcombe.
Abstract
Surface plasmon resonance (SPR) permits the quantitative analysis of therapeutic antibody concentrations and impurities including bacteria, Protein A, Protein G and small molecule ligands leached from chromatography media. The use of surface plasmon resonance has gained popularity within the biopharmaceutical industry due to the automated, label free, real time interaction that may be exploited when using this method. The application areas to assess protein interactions and develop analytical methods for biopharmaceutical downstream process development, quality control, and in-process monitoring are reviewed. 2009 Elsevier B.V. All rights reserved.Mesh:
Substances:
Year: 2009 PMID: 19762290 DOI: 10.1016/j.jchromb.2009.08.040
Source DB: PubMed Journal: J Chromatogr B Analyt Technol Biomed Life Sci ISSN: 1570-0232 Impact factor: 3.205